- Text Correction
There was an error in the original publication []. Reference [100]: “Hu, J.M.; He, L.J.; Wang, P.B.; Yu, Y.; Ye, Y.P.; Liang, L. Antagonist Targeting miR-106b-5p Attenuates Acute Renal Injury by Regulating Renal Function, Apoptosis and Autophagy Via the Upregulation of Tcf4. Int. J. Mol. Med. 2021, 48, 169.” was retracted on 29 January 2024, prior to the publication of this article. The authors were unaware of the retraction at the time of submission to ncRNA and have confirmed that Reference number 100 is not essential to their paper.
A correction has been made to Discussion, The Most Dysregulated miRNA Signatures in Kidney Diseases, Paragraph 13 and the following sentence was deleted: “The upregulation of miR-106b in rat kidneys subjected to ischemia/reperfusion injury reduced cell proliferation and promoted apoptosis and autophagy by targeting transcription factor 4 (TCF4) [100]”. The order of later references has been adjusted accordingly.
In addition, the corresponding author has a new email address which was updated in the original publication [].
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Garmaa, G.; Bunduc, S.; Kói, T.; Hegyi, P.; Csupor, D.; Ganbat, D.; Dembrovszky, F.; Meznerics, F.A.; Nasirzadeh, A.; Barbagallo, C.; et al. A Systematic Review and Meta-Analysis of microRNA Profiling Studies in Chronic Kidney Diseases. Non-Coding RNA 2024, 10, 30. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).